Lei's questions to Merit Medical Systems Inc (MMSI) leadership • Q2 2025
Question
Lei, on behalf of Larry Biegelsen at Wells Fargo, asked why the full-year revenue guidance was raised by less than the Q2 revenue beat and whether the Rhapsody delay was the only factor. She also inquired about the company's ability to offset tariff impacts in 2026.
Answer
CFO Raul Parra explained that while they flow through a portion of quarterly beats, they remain cautious given macro uncertainties, including the dynamic tariff environment. He affirmed high confidence in the updated guidance. Regarding 2026 tariffs, he stated that while their mitigation plans are intact, the final impact depends on future policy decisions, but emphasized their commitment to their long-term CGI targets remains unchanged.